Covid-19: Novavax applies to Medsafe for vaccine use in New Zealand – Stuff.co.nz

Biotechnology company Novavax has filed for provisional approval to use its Covid-19 vaccine in New Zealand.
The application is now before drug safety regulator Medsafe, the company announced in a statement.
It isthe first application related to a protein-based…

Click here to view the original article.